Lymphoplasmacytic Lymphoma Completed Phase 3 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0031072 (Lymphoplasmacytic Lymphoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00566332Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström MacroglobulinemiaTreatment